Cargando…
Inhibition of LPS-induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist
BACKGROUND: Inhaled lipopolysaccharide (LPS) induces a dose-dependent, acute neutrophilic response in the airways of healthy volunteers that can be quantified in induced sputum. Chemokines, such as CXCL1 and CXCL8, play an important role in neutrophilic inflammation in the lung through the activatio...
Autores principales: | Leaker, Brian R, Barnes, Peter J, O’Connor, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867427/ https://www.ncbi.nlm.nih.gov/pubmed/24341382 http://dx.doi.org/10.1186/1465-9921-14-137 |
Ejemplares similares
-
CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice
por: Mattos, Matheus Silverio, et al.
Publicado: (2020) -
Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial
por: O'Connor, Brian J, et al.
Publicado: (2011) -
Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers
por: Cullberg, Marie, et al.
Publicado: (2018) -
Bronchoabsorption; a novel bronchoscopic technique to improve biomarker sampling of the airway
por: Leaker, BR, et al.
Publicado: (2015) -
An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation
por: Harms, Mirja, et al.
Publicado: (2021)